{"id":"https://openalex.org/W1970698968","doi":"https://doi.org/10.1158/1538-7445.am2013-2745","title":"Abstract 2745: AKR1C3 is a potential biomarker of T-cell acute lymphoblastic leukemia sensitivity to the pre-prodrug PR-104.","display_name":"Abstract 2745: AKR1C3 is a potential biomarker of T-cell acute lymphoblastic leukemia sensitivity to the pre-prodrug PR-104.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W1970698968","doi":"https://doi.org/10.1158/1538-7445.am2013-2745","mag":"1970698968"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-2745","doi":"https://doi.org/10.1158/1538-7445.am2013-2745","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2745","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070657802","display_name":"Donya Moradi Manesh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Donya Moradi Manesh","raw_affiliation_strings":["1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170888","display_name":"Hern\u00e1n Carol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Hernan Carol","raw_affiliation_strings":["1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102933279","display_name":"Kathryn Evans","orcid":"https://orcid.org/0000-0001-8737-6358","observed_orcids":["https://orcid.org/0000-0001-8737-6358"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kathryn Evans","raw_affiliation_strings":["1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102858434","display_name":"Jennifer Richmond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jennifer Richmond","raw_affiliation_strings":["1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078146193","display_name":"Stephen M. F. Jamieson","orcid":"https://orcid.org/0000-0002-5485-9211","observed_orcids":["https://orcid.org/0000-0002-5485-9211"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Stephen Jamieson","raw_affiliation_strings":["2Auckland Cancer Society Research Centre, The University of Auckland, New Zealand;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Auckland Cancer Society Research Centre, The University of Auckland, New Zealand;","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087508568","display_name":"William Robert Wilson","orcid":"https://orcid.org/0000-0002-9939-8738","observed_orcids":["https://orcid.org/0000-0002-9939-8738"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"William R. Wilson","raw_affiliation_strings":["2Auckland Cancer Society Research Centre, The University of Auckland, New Zealand;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Auckland Cancer Society Research Centre, The University of Auckland, New Zealand;","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109173471","display_name":"Peter J. Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":["3Nationwide Children's Hospital, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Nationwide Children's Hospital, Columbus, OH;","institution_ids":["https://openalex.org/I1314135232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046943976","display_name":"Malcolm Anders Smith","orcid":"https://orcid.org/0000-0001-9880-9876","observed_orcids":["https://orcid.org/0000-0001-9880-9876"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malcolm A. Smith","raw_affiliation_strings":["4Cancer Therapy Evaluation Program, NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cancer Therapy Evaluation Program, NCI, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard B. Lock","raw_affiliation_strings":["1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Cancer Institute Australia for Medical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"2745","last_page":"2745"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akr1c3","display_name":"AKR1C3","score":0.8169999718666077},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.8140000104904175},{"id":"https://openalex.org/keywords/aldo-keto-reductase","display_name":"aldo-keto reductase","score":0.824999988079071},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.5370000004768372},{"id":"https://openalex.org/keywords/dna-cross-linking","display_name":"DNA cross-linking","score":0.7630000114440918},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6579999923706055},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5289999842643738},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.6949999928474426},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.7559999823570251},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8041297197341919},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.763407826423645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5438296794891357},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5383468866348267},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5318681001663208},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48815256357192993},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47975313663482666},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.43921995162963867},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4352354407310486},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.4219000041484833},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3949543833732605},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3398582339286804},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3393607437610626},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2770370841026306},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.25216495990753174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22530758380889893},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15048518776893616},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-2745","doi":"https://doi.org/10.1158/1538-7445.am2013-2745","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2745","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1955812133","https://openalex.org/W6927154861","https://openalex.org/W1915697015","https://openalex.org/W2794071771","https://openalex.org/W2050349769","https://openalex.org/W2940843937","https://openalex.org/W1997626578","https://openalex.org/W2033850902","https://openalex.org/W4223454233","https://openalex.org/W2980154759"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"the":[2,97,193,276,362,380,421,483,490,495],"success":[3],"of":[4,64,75,96,103,137,161,203,249,265,320,330,364,382,394,402,424,476,489,494],"current":[5],"therapies":[6],"for":[7,124,379,420,498],"childhood":[8],"acute":[9,478],"lymphoblastic":[10,479],"leukemia":[11,304,480],"(ALL),":[12],"novel":[13,122,377],"treatments":[14],"are":[15,299],"required":[16],"to":[17,30,41,116,155,179,251,283,413,482],"treat":[18],"high-risk":[19,125],"or":[20],"relapsed":[21],"patients.":[22],"PR-104":[23,65,119,164,266,286,365,372,397,403],"is":[24,33,46,197,390,472],"a":[25,73,106,110,121,134,143,159,198,226,289,293,376,391,432,473],"pre-prodrug":[26,484],"hydrolyzed":[27],"in":[28,61,85,130,147,162,166,173,188,195,216,246,262,302,314,361,395,406],"vivo":[29,62,131,163,263,396],"PR-104A,":[31],"which":[32],"then":[34],"metabolized":[35],"under":[36,49],"hypoxia":[37],"by":[38,52,127,255,440],"one-electron":[39],"reductases":[40],"DNA":[42],"cross-linking":[43],"metabolites.":[44],"PR-104A":[45,168],"also":[47,153,224],"activated":[48],"aerobic":[50],"conditions":[51],"aldo-keto":[53],"reductase":[54],"1C3":[55],"(AKR1C3).":[56],"We":[57,152,223],"previously":[58],"showed":[59,101,209],"profound":[60],"efficacy":[63,104,132,264],"(550":[66],"mg/kg":[67,307,333,339],"IP":[68],"weekly":[69,308,334],"x":[70,309,335,341,343,350,352],"6)":[71],"against":[72,105,133,175],"panel":[74,136],"T-":[76],"and":[77,146,207,232,235,317,345,384,387,443],"B-ALL":[78,111,181,220],"xenografts":[79,140,182,221,250,324],"derived":[80],"from":[81],"direct":[82],"patient":[83],"explants":[84],"immune-deficient":[86],"mice.":[87],"However,":[88,355],"testing":[89,128],"at":[90,292],"doses":[91],"as":[92,94,120,142,158,253,279,281,288,375],"low":[93],"10%":[95],"MTD":[98],"(50-200":[99],"mg/kg)":[100],"retention":[102],"T-ALL":[107,126,177,217,323,429],"but":[108],"not":[109],"xenograft.":[112],"This":[113,436],"study":[114,437],"aimed":[115,154],"further":[117],"evaluate":[118,156],"treatment":[123,381],"its":[129],"large":[135],"pediatric":[138],"ALL":[139],"both":[141],"single":[144,290],"agent":[145,291],"combination":[148,363],"with":[149,219,245,326,366,409,428],"established":[150,410],"drugs.":[151],"AKR1C3":[157,211,230,240,389,471],"biomarker":[160,393,475],"sensitivity":[165,196,248,481],"T-ALL.":[167],"was":[169,213,267,311,359,438],"significantly":[170,214,243],"more":[171,312],"cytotoxic":[172],"vitro":[174,247],"8":[176,180],"compared":[178,218,325],"(median":[183],"IC50":[184],"value":[185],"9-fold":[186],"higher":[187,215],"B-ALL;":[189],"P<0.0001),":[190],"indicating":[191],"that":[192,210,295,298,371,388,404],"difference":[194],"cell-intrinsic":[199],"phenomenon.":[200],"Microarray":[201],"analysis":[202],"gene":[204],"expression,":[205],"qRT-PCR":[206],"immunoblotting":[208],"expression":[212,234,242],"(P<0.01).":[222],"observed":[225,360],"strong":[227],"correlation":[228],"between":[229],"mRNA":[231],"protein":[233,241],"enzymatic":[236],"activity":[237],"(P<0.0001).":[238],"Moreover,":[239],"correlated":[244],"PR104A":[252],"assessed":[254,268],"Alamar":[256],"blue":[257],"cytotoxicity":[258],"assay":[259],"(P=0.0003).":[260],"The":[261,399],"using":[269],"stringent":[270],"objective":[271],"response":[272],"criteria":[273],"modeled":[274],"after":[275],"clinical":[277,422],"setting,":[278],"well":[280],"time":[282],"event":[284],"measurements.":[285],"administered":[287],"dose":[294],"provides":[296],"pharmacokinetics":[297],"readily":[300],"achievable":[301],"adult":[303],"patients":[305,427],"(200":[306],"2)":[310,344,353],"effective":[313],"inducing":[315],"regression":[316],"progression":[318],"delay":[319],"3/3":[321],"chemoresistant":[322,385],"an":[327],"induction-type":[328],"regimen":[329],"vincristine":[331],"(0.15":[332],"2),":[336],"dexamethasone":[337],"(5":[338],"daily":[340,349],"5":[342,351],"L-asparaginase":[346],"(1,000":[347],"KU/kg":[348],"(VXL).":[354],"no":[356],"therapeutic":[357,407],"enhancement":[358],"VXL.":[367],"These":[368],"results":[369],"indicate":[370],"shows":[373],"promise":[374],"therapy":[378],"aggressive":[383],"T-ALL,":[386],"potential":[392,474],"efficacy.":[398],"optimal":[400],"combinations":[401],"result":[405],"synergy":[408],"drugs":[411],"remain":[412],"be":[414],"defined.":[415],"Our":[416],"findings":[417],"have":[418],"implications":[419],"development":[423],"PR-104,":[425],"since":[426],"may":[430],"represent":[431],"particularly":[433],"responsive":[434],"population.":[435],"supported":[439],"NCI":[441],"NO1CM42216":[442],"Proacta,":[444],"Inc.":[445],"Citation":[446],"Format:":[447],"Donya":[448],"Moradi":[449],"Manesh,":[450],"Hernan":[451],"Carol,":[452],"Kathryn":[453],"Evans,":[454],"Jennifer":[455],"Richmond,":[456],"Stephen":[457],"Jamieson,":[458],"William":[459],"R.":[460],"Wilson,":[461],"Peter":[462],"J.":[463],"Houghton,":[464],"Malcolm":[465],"A.":[466],"Smith,":[467],"Richard":[468],"B.":[469],"Lock.":[470],"T-cell":[477],"PR-104.":[485],"[abstract].":[486],"In:":[487],"Proceedings":[488],"104th":[491],"Annual":[492],"Meeting":[493],"American":[496],"Association":[497],"Cancer":[499,509],"Research;":[500],"2013":[501],"Apr":[502],"6-10;":[503],"Washington,":[504],"DC.":[505],"Philadelphia":[506],"(PA):":[507],"AACR;":[508],"Res":[510],"2013;73(8":[511],"Suppl):Abstract":[512],"nr":[513],"2745.":[514],"doi:10.1158/1538-7445.AM2013-2745":[515]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}